John C. Pottage Jr

Insider Reports History

Entity
Individual
Location
Achillion Pharmaceuticals, 300 George Street, New Haven, CT
Signature
/s/ Satyavrat Shukla, Attorney-in-Fact for John C. Pottage, Jr.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John C. Pottage Jr:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. Director Common Stock 55K $79.8K $1.45 May 29, 2024 Direct
PARDES BIOSCIENCES, INC. Director Stock Option (Right to Buy) 0 Aug 31, 2023 Direct

Insider Reports Filed by John C. Pottage Jr

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRO Spero Therapeutics, Inc. May 29, 2024 1 $0 4 May 30, 2024 Director
SPRO Spero Therapeutics, Inc. Oct 5, 2023 1 $0 4 Oct 10, 2023 Director
PRDS PARDES BIOSCIENCES, INC. Aug 31, 2023 2 $0 4 Aug 31, 2023 Director
PRDS PARDES BIOSCIENCES, INC. Jun 1, 2023 1 $0 4 Jun 2, 2023 Director
SPRO Spero Therapeutics, Inc. Sep 15, 2022 1 $0 4 Sep 19, 2022 Director
PRDS PARDES BIOSCIENCES, INC. Sep 14, 2022 1 $0 4 Sep 16, 2022 Director
PRDS PARDES BIOSCIENCES, INC. Sep 14, 2022 0 $0 3 Sep 16, 2022 Director
SPRO Spero Therapeutics, Inc. Aug 17, 2021 1 $0 4 Aug 18, 2021 Director